Type 1 Diabetes: Pathophysiology, Progression and Prevention
Approximately 1.7 million Americans have T1D, with a documented decrease in life expectancy of 14–18 years, according to CDC. Recently, a new therapeutic option has been approved to delay T1D progression in pediatric and adult patients.
This eLearning course will cover:
An overview of T1D pathophysiology
Stages and characteristics of T1D progression
Early detection and screening strategies
Evidence for teplizumab, a first-in-class preventive option
Stay informed and make a difference in T1D care. Together, we can improve lives through better care and early intervention.
Print Page
Email to a Friend